Falette NS - Search Results

1

Analysis of epidermal growth factor receptor mRNA expression by polymerase chain reaction assay in 94 human breast adenocarcinoma tumors.

Falette NS, Artagaveytia N, Rostan MC, Garin E, Bobin JY, Saez S. Falette NS, et al. Breast Cancer Res Treat. 1994;30(3):275-82. doi: 10.1007/BF00665968. Breast Cancer Res Treat. 1994. PMID: 7981445

2

Measurement of occupied and non-occupied epidermal growth factor receptor sites in 216 human breast cancer biopsies.

Falette N, Lefebvre MF, Meggouh F, Eynard M, Garin E, Saez S. Falette N, et al. Breast Cancer Res Treat. 1992 Mar;20(3):177-83. doi: 10.1007/BF01834623. Breast Cancer Res Treat. 1992. PMID: 1571570

3

1,25-Dihydroxyvitamin D3 increases epidermal growth factor receptor gene expression in BT-20 breast carcinoma cells.

Desprez PY, Poujol D, Falette N, Lefebvre MF, Saez S. Desprez PY, et al. Biochem Biophys Res Commun. 1991 Apr 15;176(1):1-6. doi: 10.1016/0006-291x(91)90880-g. Biochem Biophys Res Commun. 1991. PMID: 1673338

4

William L. McGuire Memorial Symposium. 1,25(OH)2D3 modulation of mammary tumor cell growth in vitro and in vivo.

Saez S, Falette N, Guillot C, Meggouh F, Lefebvre MF, Crepin M. Saez S, et al. Breast Cancer Res Treat. 1993;27(1-2):69-81. doi: 10.1007/BF00683194. Breast Cancer Res Treat. 1993. PMID: 8260731

5

Increased epidermal growth factor receptor level in breast cancer cells treated by 1,25-dihydroxyvitamin D3.

Falette N, Frappart L, Lefebvre MF, Saez S. Falette N, et al. Mol Cell Endocrinol. 1989 May;63(1-2):189-98. doi: 10.1016/0303-7207(89)90095-6. Mol Cell Endocrinol. 1989. PMID: 2787762

6

Epidermal growth factor and transforming growth factor alpha mRNA expression in human breast cancer biopsies; analysis in relation to estradiol, progesterone and EGF receptor content.

Artagaveytia N, Le Penven S, Falette N, Lucero R, Garófalo EG, Saez S. Artagaveytia N, et al. J Steroid Biochem Mol Biol. 1997 Feb;60(3-4):221-8. doi: 10.1016/s0960-0760(96)00188-4. J Steroid Biochem Mol Biol. 1997. PMID: 9191980

7

In vitro study of effects of 1,25 dihydroxyvitamin D3 on the morphology of human breast cancer cell line BT.20.

Frappart L, Falette N, Lefebvre MF, Bremond A, Vauzelle JL, Saez S. Frappart L, et al. Differentiation. 1989 Mar;40(1):63-9. doi: 10.1111/j.1432-0436.1989.tb00814.x. Differentiation. 1989. PMID: 2545494

8

Growth inhibitory effect of 4-hydroxy-tamoxifen on the BT-20 mammary cancer cell line.

Chouvet C, Vicard E, Frappart L, Falette N, Lefebvre MF, Saez S. Chouvet C, et al. J Steroid Biochem. 1988 Oct;31(4B):655-63. doi: 10.1016/0022-4731(88)90015-5. J Steroid Biochem. 1988. PMID: 3199811

9

Estrogen receptor gene methylation in human breast tumors.

Falette NS, Fuqua SA, Chamness GC, Cheah MS, Greene GL, McGuire WL. Falette NS, et al. Cancer Res. 1990 Jul 1;50(13):3974-8. Cancer Res. 1990. PMID: 2354445

10

Prognostic value of P53 gene mutations in a large series of node-negative breast cancer patients.

Falette N, Paperin MP, Treilleux I, Gratadour AC, Peloux N, Mignotte H, Tooke N, Löfman E, Inganäs M, Bremond A, Ozturk M, Puisieux A. Falette N, et al. Cancer Res. 1998 Apr 1;58(7):1451-5. Cancer Res. 1998. PMID: 9537247

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters